Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Connect with industry professionals using effective methods. Discover ways to enhance your network and open new opportunities.
16,127 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
As AI server demand remains robust, one legacy tech giant stands out as a buy-after-pullback play. This piece weighs ...
A patient recounts a post-discharge donation request after gallbladder removed, prompting ethics questions and invest...
As tech stocks wobble, analysts debate if the root of the selloff lies in the mechanics of leveraged single-stock ETF...
Two defendants, Real Brokerage and The Frano Team, were voluntarily dismissed without prejudice from the Taylor RESPA...
New York City's Rent Guidelines Board approved a rent freeze for one-year renewals and, for the first time, two-year ...
Regulators in Spain are sending a clear message: there will be no extensions for the EU crypto licensing deadline. Th...
As MiCA tightens EU crypto rules, licensed platforms race to absorb deposits from non-compliant venues. european cryp...
Micron Technology reports record margins and a tight memory market that underscores leverage in the AI era. Apple fac...
A pivotal quarter could set the tone for Micron in 2026. This guide breaks down what happened, why it happened, and h...
ASML and Applied Materials ride an AI-capex wave, but their business models diverge. ASML benefits from EUV pricing p...
Visa, Mastercard, and Coinbase have joined Open Standard's Open USD initiative, signaling a major pivot toward partne...